What we cover, and where it comes from
PeptideWiz News reports on regulatory actions, published research, and industry developments affecting peptides and related medications. Every article is built from a fixed allowlist of primary sources: U.S. FDA press releases, MedWatch safety communications, recalls and drug-information notices; the NIH and NIDDK; the European Medicines Agency; peer-reviewed research indexed in PubMed; registered studies on ClinicalTrials.gov; and the official press rooms of the companies involved. We do not source from peptide vendors, “research chemical” sellers, supplement affiliates, or social media.
How articles are written and reviewed
Articles are drafted with AI assistance working strictly from those primary sources, then reviewed by a person before publication. Anything touching dosing, adverse events, recalls, or safety warnings is held for human review and does not publish automatically. Every article links to the original documents it draws on, and distinguishes in its wording between a company’s own claim and an independent, peer-reviewed finding.
What we will not do
We do not state or recommend dosages, dosing schedules, or administration instructions — not even ones reported in a source. We do not give medical advice, endorse any substance, or suggest anyone start, stop, or change a protocol. That is a decision for you and a licensed provider. PeptideWiz is a tracking and organization tool, not a medical provider, and nothing in this news section is medical advice.
Accuracy and corrections
We aim to be accurate and to attribute every claim clearly. If you spot an error, email [email protected] with the article and the issue. We correct confirmed errors promptly; when a correction changes the substance of a story, we note it on the article and update its modified date.
Independence
PeptideWiz News is published by Dapper Dev LLC (d/b/a PeptideWiz). We are not sponsored by, and do not accept payment from, any drug manufacturer, compounding pharmacy, or peptide seller to cover or frame a story. Coverage decisions are made solely on relevance to our readers.